Tauriga Sciences Inc. Commences Generating Revenue Through Product Sales on Amazon

Rhea-AI Summary

Tauriga Sciences (TAUG) announced on July 14, 2021, that it has begun generating revenue through sales on Amazon.com, receiving multiple customer orders. The company is actively expanding its product listings on the platform, aiming for increased sales in the first fiscal quarter of 2022. Additionally, Tauriga's Vitamin D3 Infused Tauri-Gum was featured in WholeFoods Magazine, highlighting its market presence. The company's product line includes various infused chewing gums, and it is also pursuing pharmaceutical development for a nausea-regulating version of Tauri-Gum.

Positive

• Revenue generation initiated through Amazon sales.
• Multiple online customer orders received swiftly.
• Upcoming expansion of product listings on Amazon.
• Featured product in WholeFoods Magazine, enhancing visibility.

Negative

• None.

NEW YORK, NY, July 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced that it has commenced generating revenue, through product sales on Amazom.com (“Amazon”), the world’s largest online retailer.  As of July 14, 2021, the Company has already received multiple online customer orders – via Amazon.com.  The Company is actively listing numerous additional products on Amazon, which should result in increasing sales – for the remainder of this Operating Quarter (1^st Fiscal Quarter 2022) and beyond.      

In other news, the Company’s Golden Raspberry Flavor, Vitamin D3 Infused Tauri-Gum™ product, was recently featured in WholeFoods Magazine.  WholeFoods Magazine is the leading source for health & nutrition articles, including natural health product news.

Link to WholeFoods Magazine Article:

https://wholefoodsmagazine.com/supplements/new-products-supplements/vitamin-d3-gum/

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant), (Vitamin C + Zinc Infused Tauri-Gum™ Flavor: Pear Bellini), (Caffeine Infused Tauri-Gum™ Flavor: Cherry Lime Rickey), & (Vitamin D3 Infused Tauri-Gum™ Flavor: Golden Raspberry).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative.  This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 22, 2021, the Company announced that it had Converted its U.S. Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”.  On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.

The Company is headquartered in Wappingers Falls, New York.  In addition, the Company operates two full time E-Commerce fulfillment centers: one located in Montgomery, Texas and the other in Brooklyn, New York.

DISCLAIMER -- Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other periodic filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email:  sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram:  @sethsms47
Twitter: @SethMShaw
Corp. Website:   www.tauriga.com
E-Commerce Website:  www.taurigum.com

Attachment

• Tauriga 07-14-2021

FAQ

What recent announcement did Tauriga Sciences (TAUG) make regarding revenue?

Tauriga Sciences announced it has commenced generating revenue through product sales on Amazon.com.

How many customer orders has Tauriga Sciences (TAUG) received from Amazon?

As of July 14, 2021, Tauriga Sciences has received multiple online customer orders via Amazon.

What product was featured in WholeFoods Magazine by Tauriga Sciences (TAUG)?

Tauriga's Vitamin D3 Infused Tauri-Gum was featured in WholeFoods Magazine.

What is Tauriga Sciences' main product line?

Tauriga's main product line consists of various infused chewing gums, branded as Tauri-Gum.

What is the company's strategy for increasing sales?

Tauriga plans to actively list more products on Amazon, aiming to boost sales in the current operating quarter.